期刊文献+

嗜酸性粒细胞水平与大疱性类天疱疮激素应用剂量间的关系 被引量:12

Correlation between Blood Eosinophil Level and Steroid Doses in Patients with Bullous Pemphigoid
暂未订购
导出
摘要 目的探讨外周血嗜酸性粒细胞(EOS)水平与大疱性类天疱疮(BP)激素应用剂量间的关系。方法对82例门诊(33例)和住院(49例)的未经任何治疗的BP患者进行回顾性分析,记录BP治疗所需激素量及治疗前后外周血EOS的数量,评价EOS水平与激素应用剂量间的相关性。结果 82例初发BP患者中,EOS增高者69例(84.15%),与正常对照(10%)相比,差异具有统计学意义(t=1.99,P<0.001);44例BP患者住院后经激素治疗,病情控制前EOS一直处于较高水平,病情控制后EOS很快恢复正常,EOS数量与病情严重程度一致。经Spearman相关分析显示,EOS水平和激素治疗的最大剂量间具有直线相关性(r=0.496,P<0.001)。5例患者应用非激素疗法,治疗后EOS水平随病情好转亦随之下降。结论 EOS水平可作为激素应用剂量的参考指标之一。 Objective To evaluate the correlation between blood eosinophil(EOS)level and steroid doses in patients of bullous pemphigoid(BP).Methods A total of 82 untreated BP inpatients(n=49) and outpatients(n=33) were enrolled in this study.The blood EOS level and the steroid doses before and after treatment were recorded.The correlation between EOS level and steroid doses was analyzed retrospectively.Results EOS increased in 69 BP patients(84.15%);on the contrary,only 10% of normal controls had increased EOS(t=1.99,P〈0.001).In 44 inpatients,the blood EOS remained high before steroid treatment,and quickly returned to normal level after the disease became stable.There was a linear correlation between EOS and steroid doses(Spearman analysis,r=0.496,P〈0.001).In 5 patients who were treated by non-steroid approach,EOS level also declined after the disease was resolved.Conclusion EOS can be one of useful indicators for the application of steroids in the treatment of BP.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2012年第2期130-133,共4页 Acta Academiae Medicinae Sinicae
基金 国家自然科学基金(81071301) 新世纪优秀人才支持计划(NCET-10-0964)~~
关键词 大疱性类天疱疮 嗜酸性粒细胞 病情严重程度 bullous pemphigoid eosinophi severity of disease
  • 相关文献

参考文献13

  • 1Ujiie H,Nishie W,Shimizu H.Pathogenesis of bullouspemphigoid[J].Dermatol Clin,2011,29(3):439-446.
  • 2Wong MM,Giudice GJ,Fairley JA.Autoimmunity in bul-lous pemphigoid[J].G Ital Dermatol Venereol,2009,144(4):411-421.
  • 3Gounni Abdelilah S,Wellemans V,Agouli M,et al.In-creased expression of Th2-associated chemokines in bullouspemphigoid disease.Role of eosinophils in the productionand release of these chemokines[J].Clin Immunol,2006,120(2):220-231.
  • 4Engineer L,Bhol K,Kumari S,et al.Bullous pemphigoid:interaction of interleukin 5,anti-basement membrane zoneantibodies and eosinophils.A preliminary observation[J].Cytokine,2001,13(1):32-38.
  • 5Bernard P,Venot J,Constant F,et al.Blood eosinophiliaas a severity marker for bullous pemphigoid[J].J AmAcad Dermatol,1987,16(4):879-881.
  • 6Cugno M,Tedeschi A,Asero R,et al.Skin autoimmunityand blood coagulation[J].Autoimmununity,2010,43(2):189-194.
  • 7Toosi S,Bystryn JC.Potential role of interleukin-17 in thepathogenesis of bullous pemphigoid[J].Med Hypotheses,2010,74(4):727-728.
  • 8Simon D,Hoesli S,Roth N,et al.Eosinophil extracellularDNA traps in skin diseases[J].J Allergy Clin Immunol,2011,127(1):194-199.
  • 9Sthle-Bckdahl M,Inoue M,Guidice GJ,et al.92-kD ge-latinase is produced by eosinophils at the site of blister for-mation in bullous pemphigoid and cleaves the extracellulardomain of recombinant 180-kD bullous pemphigoid autoanti-gen[J].J Clin Invest,1994,93(5):2022-2030.
  • 10Marzano AV,Tedeschi A,Berti E,et al.Activation of coag-ulation in bullous pemphigoid and other eosinophil-relatedinflammatory skin diseases[J].Clin Exp Immunol,2011,165(1):44-50.

同被引文献65

  • 1瞿镔,许爱娥.嗜酸粒细胞增多性皮炎24例分析[J].中华皮肤科杂志,2006,39(10):606-607. 被引量:13
  • 2冯素英,靳培英,林麟,吴勤学,周武庆,桑红桂.大疱性类天疱疮疾病严重程度与BP180抗体水平关系的研究[J].中华皮肤科杂志,2007,40(4):199-201. 被引量:6
  • 3Wu J,Dalal K. Tuberculosis in asia and the pacific:the role of socioeconomic status and health system development[J].Int J Prev Med,2012.8-16.
  • 4Menzies D,Pai M,Comstock G. Meta-analysis:new tests for the diagnosis of latent tuberculosis infection:areas of uncertainty and recommendations for research[J].Annals of Internal Medicine,2007.340-354.
  • 5McAllister WAC,Thompson PJ,Al-Habet SM. Ri-fampicin reduces effectiveness and bioavailability of prednisolone[J].British Medical Journal,1983.923-925.
  • 6Pai M,Zwerling A,Menzies D. Systematic review:T-cell-based assays for the diagnosis of latent tuberculosis infec-tion:an update[J].Annals of Internal Medicine,2008.177-184.
  • 7Shovman O,Anouk M,Vinnitsky N. QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis:a pilot study[J].International Journal of Tuberculosis and Lung Disease,2009.1427-1432.
  • 8Papay P,Eser A,Winkler S. Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases[J].Inflammatory Bowel Diseases,2011.84-90.
  • 9Ibn Sellam A,Soualhi M,Zahraoui R. A rare form of rifampicin-induced skin toxicity:Bullous pemphigoid[J].Revue Des Maladies Respiratoires,2011.365-371.
  • 10Bernard P,Venot J,Constant F. Blood eosinophilia as a severity marker for bullous pemphigoid[J].Journal of the American Academy of Dermatology,1987.879-881.

引证文献12

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部